Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2025

 
   Single User - $995
   Site License (one location, 10 users) - $1,495
   Corporate License - $1,990



Loading...
Published Jul 27, 2016 | 340 Pages | Pub ID: KLI15068137

Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2025



The pharmaceutical market has witnessed a number of significant changes in recent years, providing both setbacks and new opportunities. The number of blockbuster pharmaceuticals reaching patent and exclusivity expiration status and vulnerable to generic competition has changed the landscape of the market for many manufacturers. The growing interest in biotechnology development has transitioned an industry once focused on chemical-based therapies to biologic therapies and produced exceptional changes in many areas of medical treatment over the last two decades. Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2025 examines the leaders in the pharmaceutical industry, including the late-term pipeline of major companies. This report provides long-term company sales forecasts based recent market conditions. For each company covered, the report provides:
  • Corporate Summary
  • Total Company Revenue and Total R&D Spending 2011-2015
  • Break-up of Sales by Region, 2015
  • Pharmaceutical Business Performance, 2011-2015 and Forecasted 2025
  • Pharmaceutical Segment Sales, 2011 through 2015 and Forecasted 2025
  • Leading Pharmaceutical Products, 2015 Sales
  • Late Stage Product Pipeline
  • Late Stage Product Pipeline by Therapeutic Area, Comparing 2009, 2011, 2013 and 2015
  • Corporate Development Details
The top 25 pharmaceutical companies included in the study are:
  • AbbVie
  • Allergan
  • Amgen
  • Astellas
  • AstraZeneca
  • Bayer
  • Biogen
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Celgene Corp.
  • Daiichi Sankyo
  • Eli Lilly & Co.
  • Gilead Sciences
  • GlaxoSmithKline
  • Johnson & Johnson
  • Merck
  • Mylan
  • Novartis
  • Novo Nordisk
  • Otsuka Pharmaceutical
  • Pfizer
  • Roche
  • Sanofi
  • Takeda
  • TEVA
Despite the new approaches, new technologies and a wealth of new information, drug R&D is still challenged by understanding exactly how drugs will work and why they may fail. Target validation remains a quandary as well. Thus, the hurdle of getting past Phase III trials and launching more NMEs continues. Top 25 Pharmaceutical Company Pipeline Analysis and Sales Projections to 2025 provides a thorough discussion of current trends in pharmaceutical research and development, including:
  • Pharmaceutical Research & Development Challenge
  • The Drug Approval Process
  • Expanded Options in Treating Diseases
  • Biotechnology Drug Development
  • Orphan Drugs
  • Fast Track Drug Status
  • Other Accelerated Methods for Drug Approval
  • Pharmaceutical Regulatory Exclusivity
  • The Role of Contract Research Organizations
The report also looks at market trends and values by therapeutic area, providing information on the following segments:
  • Top 5 Cardiovascular/Blood Therapeutic Companies, 2015 Sales
  • Top 5 Neurotherapeutic Companies, 2015 Sales
  • Top 5 Infection Treatment Companies, 2015 Sales
  • Top 5 Oncology Companies, 2015 Sales
  • Top 5 Respiratory and Inflammation Product Companies, 2015 Sales
  • Top 5 Other Drug Companies, 2015 Sales
In addition to its company focus, the report examines the global pharmaceutical market, which has continued its recovery from the economic downfall experienced in recent years. Healthcare costs as a percent of GDP are increasing in almost all countries, though there are some exceptions. There are a number of macroeconomic concerns affecting sales such as aging populations, incidence of disease, unmet medical needs, government activities, and more. Data provided include:
  • Global Pharmaceutical Projects in Development by Therapeutic Segment
  • Global Pharmaceutical Market, 2011-2015 and Forecasted 2025
  • Global Pharmaceutical Market by Therapeutic Area, 2011-2015 and Forecasted 2025
  • Global Pharmaceutical Market % Change by Therapeutic Segment, 2014-2015
  • Top Pharmaceutical Companies, 1-25 by 2015 Pharmaceutical Sales
  • Top Companies by 2015 Pharmaceutical Sales Growth
  • Global Pharmaceutical Market, Sales Growth by Company, 2014- 2015
  • Top 25 Pharmaceutical Companies by Annual Pharmaceutical Sales, 2015 Compared to 2011 and 2013
  • Top 50 Pharmaceutical Products, by 2013 and 2015 Revenues
  • Global Pharmaceutical Market Forecast by Therapeutic Segment, 2025—based on late stage development projects evaluated
  • Evaluating Pharmaceutical Company Growth, 2015-2025
  • Total Healthcare Expenditures as a Percent of GDP by Country 2010 and 2015 Estimates (Australia, Austria, Canada, Czech Republic, Finland, France, Germany, Greece, Italy, Japan, Mexico, Switzerland, United Kingdom, United States)
  • International Population Trend Age 65+
For the purpose of this study, Kalorama Information has extracted sales for human pharmaceutical, including biopharmaceutical products. The market excludes consumer pharmaceuticals, diagnostics, devices, chemicals, agriculture and animal health. These are areas where many of these companies also compete with significant market shares.

Also, despite an in-depth interview process and complete review of the top 25 pharmaceutical companies' financials and literature, some variation in company rankings is possible. This is more likely with privately held companies or companies where prescription pharmaceutical sales are not discussed.

This report provides long-term company sales forecasts, which are based on 2015 market conditions. Company forecasts were derived from a combination of pipeline analyses, current product reviews, patent and exclusivity activities, recent merger and alliance impacts, and a number of other factors discovered throughout the writing of this report.
In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.